Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
Employees - 55,
CEO - Mr. Robert M. Hayes,
Sector - Healthcare,
Country - US,
Market Cap - 0.32M
Altman ZScore(max is 10): -11.23, Piotroski Score(max is 10): 4, Working Capital: $-2011679, Total Assets: $7313748, Retained Earnings: $-34445206, EBIT: -9626709, Total Liabilities: $5317619, Revenue: $8226
- Current Price $0.02 - Analyst Target Price $352.00| Ticker | STSS |
| Index | - |
| Curent Price | 0.02 |
| Change | -9.35% |
| Market Cap | 0.32M |
| Average Volume | 105.53M |
| Income | -9.30M |
| Sales | 0.00M |
| Book Value/Share | 0.97 |
| Cash/Share | 0.07 |
| Dividend Est | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Employees | 55 |
| Moving Avg 20days | -28.57% |
| Moving Avg 50days | -90.04% |
| Moving Avg 200days | -99.28% |
| Shares Outstanding | 16.33M |
| Earnings Date | - |
| Inst. Ownership | 3.28% |
| Price/Earnings | - |
| Forwad P/E | - |
| PE Growth | - |
| Price/Sales | - |
| Price/Book | 0.02 |
| Price/Cash | 0.29 |
| Price/FCF | - |
| Quick Ratio | 0.25 |
| Current Ratio | 0.61 |
| Debt/Equity | 1.88 |
| Return on Assets | -97.33% |
| Return on Equity | -187.23% |
| Return on Investment | -465.71% |
| Gross Margin | - |
| Ops Margin | - |
| Profit Margin | - |
| RSI | 29.49 |
| BETA(β) | 2.13 |
| From 52week Low | 73.21% |
| From 52week High | -99.89% |
| EPS | -6.78 |
| EPS next Year | - |
| EPS next Qtr | - |
| EPS this Year | - |
| EPS next 5 Year | - |
| EPS past 5 Year | -8.46% |
| Sales past 5 Year | 0.00% |
| EPS Y/Y | 61.22% |
| Sales Y/Y | - |
| EPS Q/Q | 50.53% |
| Sales Q/Q | - |
| Sales Surprise | -100.00% |
| EPS Surprise | -175.00% |
| ATR(14) | 0.03 |
| Perf Week | -39.38% |
| Perf Month | -88.67% |
| Perf Quarter | -98.82% |
| Perf Year | -99.70% |
| Perf YTD | -99.06% |
| Target Price | 352.00 |
AryaFin Engine© - An AI FinTech Venture - 2024-25 Disclaimer